Patents by Inventor Susan B Dillon

Susan B Dillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human immunodeficiency virus gp41 mimetibody polypeptides
    Patent number: 7744897
    Abstract: HIV gp41 mimetibody polypeptides and encoding polynucleotides are disclosed. Methods of utilizing the polypeptides to reduce or inhibit HIV fusion with a cell membrane and entry into target cells are also disclosed.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: June 29, 2010
    Inventors: Susan B. Dillon, Alfred Michael Del Vecchio, Chichi Huang, Karyn T. O'Neil, Robert T. Sarisky
  • Use of il-8 receptor antagonists in the treatment of virus infections
    Publication number: 20040038854
    Abstract: The present invention is directed to the novel use of an IL-8 receptor antagonist for the treatment of human virus infections and the exacerbation of symptoms associated therewith.
    Type: Application
    Filed: January 15, 2003
    Publication date: February 26, 2004
    Inventors: Susan B. Dillon, Ruth Tal-Singer
  • Use of il-8 protein modulators in the treatment of viral infections
    Publication number: 20040022762
    Abstract: The present invention is directed to the novel use of an IL-8 protein modulator for the treatment of human virus infections and associated symptom exacerbations.
    Type: Application
    Filed: March 19, 2003
    Publication date: February 5, 2004
    Inventors: Susan B Dillon, Ruth Tal-Singer
  • Method of treating anemia
    Publication number: 20030176375
    Abstract: hYAK3-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed.
    Type: Application
    Filed: May 14, 2001
    Publication date: September 18, 2003
    Inventors: Kenneth A. Lord, Susan B. Dillon, Caretha Creasy
  • Methods of treating viral diseases with il-18 and il-18 combinations
    Publication number: 20030113292
    Abstract: The present invention relates generally to the use of compositions comprising IL-18, also known as interferon-&ggr;-inducing factor (IGIF), and IL-18 in combination with other agents, for the prevention and/or treatment of viral diseases caused by HIV, HSV, HPV, HAV, HBV, and HCV.
    Type: Application
    Filed: December 2, 2002
    Publication date: June 19, 2003
    Inventors: Klaus M Esser, Martin Rosenberg, Ruth Tal-Singer, Gary Woodnutt, Francis V Chisari, Susan B Dillon
  • Substituted imidazoles having anti-cancer and cytokine inhibitory activity
    Patent number: 6548520
    Abstract: The present invention is related to novel 2-alkyl substituted imidazoles of formula (I) useful for the treatment of CSBP kinase mediated diseases.
    Type: Grant
    Filed: March 3, 2001
    Date of Patent: April 15, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Susan B. Dillon, Sandra D. Griego, Dennis Lee
  • Use of PDE 4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection
    Patent number: 6436971
    Abstract: This invention relates to a method for the prophylaxis of or reducing the severity of post-viral bacterial infection by administering a PDE 4-specific inhibitor prior to or during the course of a viral infection or thereafter during the course of the bacterial infection.
    Type: Grant
    Filed: February 8, 2001
    Date of Patent: August 20, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Peter L. DeMarsh, Susan B. Dillon, Gary Woodnutt
  • EPO primary response gene, EPRG3pt
    Publication number: 20020065238
    Abstract: EPRG3pt polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing EPRG3pt polypeptides and polynucleotides in therapy, and diagnostic assays for such.
    Type: Application
    Filed: February 22, 2001
    Publication date: May 30, 2002
    Inventors: Susan B. Dillon, Kenneth A. Lord
  • Human protein kinases hYAK3-2
    Patent number: 6323318
    Abstract: hYAK3-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: November 27, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Kenneth A. Lord, Susan B. Dillon, Caretha Creasy
  • Use of PDE-4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection
    Publication number: 20010041739
    Abstract: This invention relates to a method for the prophylaxis of or reducing the severity of post-viral bacterial infection by administering a PDE 4-specific inhibitor prior to or during the course of a viral infection or thereafter during the course of the bacterial infection.
    Type: Application
    Filed: February 8, 2001
    Publication date: November 15, 2001
    Inventors: Peter L. DeMarsh, Susan B. Dillon, Gary Woodnutt
  • EPO primary response gene, EPRG3Spt
    Patent number: 6306604
    Abstract: EPRG3Spt polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing EPRG3Spt polypeptides and polynucleotides in therapy, and diagnostic assays for such.
    Type: Grant
    Filed: January 31, 2000
    Date of Patent: October 23, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Susan B Dillon, Kenneth A Lord